# EagleRock Land, LLC: financial statements, quarterly

EROK · NYSE · CIK 2104882 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/erok.md) · [Financials](/companies/erok/financials.md) · [Filings](/companies/erok/filings.md) · [Insiders](/companies/erok/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/erok/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [23.9](/filings/0001193125-26-349110.md) | [41.5](/filings/0001193125-26-349110.md) |
| Operating income | $m | [5.3](/filings/0001193125-26-349110.md) | [(53.2)](/filings/0001193125-26-349110.md) |
| Interest expense | $m | [6.1](/filings/0001193125-26-349110.md) | [4.8](/filings/0001193125-26-349110.md) |
| Income tax | $m | [0.0](/filings/0001193125-26-349110.md) | [(0.1)](/filings/0001193125-26-349110.md) |
| Net income | $m | [(70.8)](/filings/0001193125-26-349110.md) | [(7.6)](/filings/0001193125-26-349110.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.0](/filings/0001193125-26-349110.md) | not reported | [61.8](/filings/0001193125-26-349110.md) |
| Current assets | $m | [31.2](/filings/0001193125-26-349110.md) | not reported | [90.1](/filings/0001193125-26-349110.md) |
| Total assets | $m | [282](/filings/0001193125-26-349110.md) | [0.0](/filings/0001193125-26-279687.md) | [1,796](/filings/0001193125-26-349110.md) |
| Current liabilities | $m | [17.1](/filings/0001193125-26-349110.md) | not reported | [43.7](/filings/0001193125-26-349110.md) |
| Total liabilities | $m | [0.0](/filings/0001193125-26-279687.md) | [0.0](/filings/0001193125-26-279687.md) | not reported |
| Long-term debt | $m | [295](/filings/0001193125-26-349110.md) | not reported | not reported |
| Current portion of debt | $m | [6.0](/filings/0001193125-26-349110.md) | not reported | not reported |
| Shareholders' equity | $m | [(41.7)](/filings/0001193125-26-349110.md) | [(38.4)](/filings/0001193125-26-349110.md) | [328](/filings/0001193125-26-349110.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.